Inhibiting Antimicrobial Resistance by Blocking Bacterial Necrosignal Transmission Using Kimchi LAB Metabolites
ISEF · 2023 Microbiology
Overview
In 2019, 2.8 million cases of antimicrobial-resistant infections have occurred, and 35,000 people have died as a result. Even the World Health Organization (WHO) recognizes bacterial resistance as one of the greatest threats to global health and food security. Previously, it was understood that bacteria that survive direct exposure to antibiotics acquire antibiotic resistance traits; however, according to a 2020 study by Bhattacharyya et al., a novel mechanism of resistance acquisition was introduced: dying bacteria transfer resistance-enhancing factor AcrA to living bacteria through a process called necrosignaling. Kimchi, a traditional Korean food, contains various lactic acid bacteria (LAB) depending on fermentation stage, or period, and it is well-known that LAB and its metabolites are effective in inhibiting the proliferation of harmful bacteria. Therefore, the purpose of this study was to prove whether the metabolites released by kimchi LAB of various fermentation stages could block the transfer of necrosignals, a newly discovered mechanism for generating resistant bacteria. Dying E. coli was applied on one side of LB agar plates, and kimchi metabolites were injected into their borders. Agar diffusion tests were performed with E. coli on the other side of the agar plates. It was found that E. coli evolved into resistant bacteria due to necrosignals, and kimchi LAB metabolites, especially of moderate fermentation, blocked the transmission of these signals. In addition, the activity of kimchi metabolites was maintained even after treatment under extreme environments. Thus, kimchi postbiotics could be used as a potential treatment to counter the outbreak of bacterial resistance.
Competition history
- ISEF 2023
Resources
Related projects
ISEF · 2017
Using Microbial Metabolites to Develop an Alternative to Combat Klebsiella pneumoniae carbapenemase (KPC)
ISEF · 2024
Next-Generation Antibiotics: Isolating and Screening Novel Bacteriocins
ISEF · 2026
Targeting the GraRS Two-Component System in Staphylococcus epidermidis: Computational Identification and in vitro Validation of a Novel Adjunctive Cocktail Therapy for Antibiotic-Resistant Infections
ISEF · 2025
Understanding the Synergy Between Antibiotics and Phenolic Acids
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair